First in class treatment to enhance stroke recovery

Important results from the project

The purpose of the project was to take decisive steps in the development of the company´s treatment to improve the brain´s recovery after stroke where the goal was to validate the company´s previously developed (for other indications) drug candidate and to develop in collaboration with Key Opinion Leaders a study protocol to the planned clinical proof of concept studies. The goals have been met

Expected long term effects

If the company´s previously developed drug candidate is judged to be able to be used as it is and a new batch is not needed, the company can focus on formulation and completion before the upcoming clinical study, which saves time and money. The outcome is positive and enables the next step in development. A study protocol developed in collaboration with Key Opinion Leaders enables contacts with authorities to obtain permission to carry out the planned proof of concept study in humans. This objective has been achieved.

Approach and implementation

The project has been carried out in close collaboration with the research institute RISE Södertälje in terms of tests and production of documentation of the company´s drug candidate. A number of international Key Opinion Leaders have been contracted and in a decisive way contributed to the development of the protocol. Due to the pandemic, this work has unfortunately been delayed but has been completed within the time frame given in the notification of change.